Five patients with thrombotic thrombocytopenic purpura (TTP) were treated with corticosteroids, plasma exchange (PE), and antiplatelet agents. ABO-and Rh-compatible fresh-frozen plasma (FFP) was used as the replacement fluid. None of the patients received FFP infusion without PE. The patients were
Plasma exchange for treatment of thrombotic thrombocytopenic purpura in critically ill patients
✍ Scribed by P. Knöbl; C. Rintelen; G. Kornek; C. Wiltschke; P. Kalhs; I. Schwarzinger; S. Globits; T. Staudinger; K. Laczika; P. Kyrle; M. Frass
- Publisher
- Springer
- Year
- 1997
- Tongue
- English
- Weight
- 94 KB
- Volume
- 23
- Category
- Article
- ISSN
- 1432-1238
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract To a limited extent, thrombotic thrombocytopenic purpura (TTP) in addition to its clinical features is being defined nowadays with laboratory tests such as the assay for the Von Willebrand factor‐cleaving protease (ADAMTS 13) and its antibody. We present a case report of a patient with
## Abstract Thrombotic thrombocytopenic purpura (TTP) after bone marrow transplantation (BMT) is an uncommon complication presumably associated with extensive endothelial cell damage due to Cyclosporine, total body irradiation, or other drugs. While the majority of patients with primary TTP, which